ACAD

NASDAQStock

ACADIA Pharmaceuticals Inc.

$21.33-0.65 (-2.96%)

52-Week Range

$14.10

$28.06

Key Stats

Market Cap

3.6B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81

Volume

744.9K

Avg Volume

2.0M

Performance

-5.34%

-21.97%

-13.78%

YTD

-19.09%

+26.76%

+4.37%

-29.08%

Price Chart

ETF Exposure

ACAD is held by 136 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DFAU	Dimensional - US Core Equity Market ETF	0.01%	32,900	$742K	$10.55B	0.12%
ESGV	Vanguard ESG U.S. Stock ETF	0.01%	27,120	$682K	$11.90B	0.09%
SCHB	Schwab U.S. Broad Market ETF	0.01%	76,828	$1.7M	$38.14B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.01%	10,503	$264K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.01%	4,001,731	$100.6M	$2.10T	0.03%
DFUS	Dimensional - US Equity Market ETF	0.00%	35,634	$803K	$18.80B	0.09%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	154,527	$3.5M	$81.53B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	34,756	$783K	$17.58B	0.20%
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.00%	23,812	$538K	$12.10B	0.03%
TILT	FlexShares Morningstar U.S. Market Factor Tilt Index Fund	0.00%	3,792	$85K	$1.90B	0.26%
V3AL.L	Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.00%	2,510	$63K	$1.46B	0.24%
VLU	State Street SPDR S&P 1500 Value Tilt ETF	0.00%	972	$22K	$618.9M	0.12%
GTPE	Goldman Sachs MSCI World Private Equity Return Tracker ETF	0.00%	80	$2K	$26.4M	0.50%
VT	Vanguard Total World Stock ETF	0.00%	90,211	$2.3M	$80.60B	0.06%
AVSU	Avantis Responsible U.S. Equity ETF	0.00%	321	$7K	$412.5M	0.15%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	80	$2K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	67	$2K	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	44	$995	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	33	$752	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	15	$334	$9.5M	0.12%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	2,805	$63K	$2.84B	0.19%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	846	$19K	$1.69B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	2,443	$55K	$3.28B	0.20%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	59	$1K	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	68	$2K	$64.1M	0.11%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	276	$6K	$733.2M	0.20%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	163	$4K	$694.1M	0.23%
AVUS	Avantis U.S. Equity ETF	0.00%	296	$7K	$11.08B	0.15%
CHEP	AGFiQ U.S. Market Neutral Value Fund	0.00%	-68	$0	$747K	1.42%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	10	$236	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	35	$781	$81.5M	0.10%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	2,643	$69K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	2,643	$69K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	2,643	$69K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	2,643	$69K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	2,643	$69K	$3.7M	0.70%

PreviousPage 3 of 3

About ACAD ETF Exposure

ACADIA Pharmaceuticals Inc. (ACAD) is held by 136 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 3.6B, ACAD is a widely held institutional stock. The stock currently trades at $21.33. Investors can gain exposure to ACAD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ACAD, sorted by portfolio weight.